Last €69.27 EUR
Change Today +0.87 / 1.27%
Volume 325.0
LO3 On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
OTC US
Singapore
Frankfurt
OTC US
As of 10:24 AM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

lonza group ag-reg (LO3) Snapshot

Open
€68.28
Previous Close
€68.40
Day High
€69.27
Day Low
€67.95
52 Week High
01/24/14 - €76.35
52 Week Low
04/24/13 - €50.03
Market Cap
3.7B
Average Volume 10 Days
209.6
EPS TTM
--
Shares Outstanding
52.9M
EX-Date
04/22/14
P/E TM
--
Dividend
€2.15
Dividend Yield
2.53%
Current Stock Chart for LONZA GROUP AG-REG (LO3)

Related News

No related news articles were found.

lonza group ag-reg (LO3) Related Businessweek News

View More BusinessWeek News

lonza group ag-reg (LO3) Details

Lonza Group Ltd. supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. It operates in two segments, Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech segment develops and manufactures active pharmaceutical ingredients (APIs) for drug companies; microbial parenteral API, including antibody fragments, vaccines, cytokines, plasmid DNA, fusion proteins, and PEGylated products; and chemical custom services, such as chemically derived active ingredients, antibody drug conjugates, and cytotoxic and peptide syntheses, as well as biological cellular and gene therapies. This segment also offers cell culture, transfection, and molecular biology tools for lifescience research; media used in the production of therapeutics; endotoxin detection assays; products and services targeting cardiovascular, respiratory, neurological, metabolic, cancer, and other disease research areas; and cell biology solutions to enhance efficiencies in research. This segment serves customers in academic and government institutions, and in biotech and pharmaceutical organizations. The Specialty Ingredients segment offers personal care and preservation products comprising actives for antidandruff shampoos, and natural and organic cosmetic ingredients; vitamin B3 compounds and L-Carnitine, as well as nutritional ingredients used in pharmaceuticals, human energy drinks, and animal feeds; and microbial control solutions, including disinfectants and sanitizers that protect from dangerous and unwanted microbes. This segment also provides custom agricultural manufacturing services to enhance crop yields; sanitizers and other treatment chemicals, as well as feeder systems for drinking water disinfection and surface-water treatments; industrial Solutions, such as preservatives and biocide blends; and products and services that enhance the quality of wood. The company was founded in 1897 and is headquartered in Basel, Switzerland.

9,935 Employees
Last Reported Date: 03/20/14
Founded in 1897

lonza group ag-reg (LO3) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lonza group ag-reg (LO3) Key Developments

Lonza Group Declares Final Dividend for the Year Ended December 31, 2013, Payable on April 25, 2014

Lonza Group has declared a final dividend of CHF 2.15 per share for the year ended December 31, 2013, with record date of April 24, 2014 and payment date of April 25, 2014.

Lonza Group Ltd Approves the Revision of the Articles of Association

Lonza Group Ltd. announced that the Annual General Meeting of shareholders of the company was held on April 16, 2014, has approved the revision of the Articles of Association to align them with the requirements of the Swiss Ordinance Against Excessive Compensation by Public Corporations.

Lonza Group AG Appoints Barbara Richmond as a Non-Executive Director

Redrow plc announced that Barbara Richmond, Group Finance Director, has been appointed a Non-Executive Director of Lonza Group Ltd, Basel, Switzerland.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LO3:GR €69.27 EUR +0.87

LO3 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Albemarle Corp $67.07 USD -0.67
Ashland Inc $97.25 USD -0.34
Clariant AG SFr.17.24 CHF +0.06
Dr Reddy's Laboratories Ltd 2,566 INR +13.30
Piramal Enterprises Ltd 584.15 INR -3.15
View Industry Companies
 

Industry Analysis

LO3

Industry Average

Valuation LO3 Industry Range
Price/Earnings 50.6x
Price/Sales 1.2x
Price/Book 2.1x
Price/Cash Flow 51.3x
TEV/Sales 0.5x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LONZA GROUP AG-REG, please visit www.lonza.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.